Sumitomo Pharma America and Actor Holly Robinson Peete Encourage People with Overactive Bladder to Speak Up and Seek Treatment | PR Newswire [Video]

• Marking the third year, the Time To Go™ campaign features Holly Robinson Peete in conversation with real-life patients sharing about their experiences managing the disruptive condition of OAB and treatment journey on GEMTESA^® (vibegron)

, /PRNewswire/ — Sumitomo Pharma America, Inc. (SMPA), today announced the continuation of its partnership with actor and overactive bladder (OAB) patient Holly Robinson Peete to reach people with OAB through the Time To Go™ campaign. Time to Go is a platform designed to highlight the impact of OAB symptoms and educate on disease management, including information on treatment options, such as GEMTESA^® (vibegron).

GEMTESA is a prescription medication for the treatment of OAB in adults with symptoms of urge urinary incontinence, urgency, and frequency. OAB causes sudden urges to urinate that are difficult to control and can result in leakage, as well as frequent urination — usually eight or more times a day.¹

In the third …